| Dr Jack Leitner, MD | |
|
95 Lincoln St, Framingham, MA 01702 | |
| (508) 875-1964 | |
| (508) 626-7690 |
| Full Name | Dr Jack Leitner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Medical Oncology |
| Location | 95 Lincoln St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205975067 | NPI | - | NPPES |
| 2017725 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 31597 (Massachusetts) | Primary |
| 207RX0202X | Internal Medicine - Medical Oncology | 31597 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jack Leitner, MD 95 Lincoln St, Framingham, MA 01702 Ph: (508) 875-1964 | Dr Jack Leitner, MD 95 Lincoln St, Framingham, MA 01702 Ph: (508) 875-1964 |
News Archive
Leishmaniasis is an important human and veterinary disease caused by Leishmania parasites that affect 12 million people in over 98 endemic countries. The disease is now emerging in Europe due to climate change and massive population displacement.
How can research in food and diets address how we will live and eat in 2050? By supporting the move towards individualised diets; by ensuring the sustainability of the future food system; by improving our understanding of links between food, nutrients and health; and by focusing on integrated policy-making.
Tenet Healthcare Corporation today announced it has withdrawn from preliminary discussions regarding a potential acquisition of the Australian private hospital operator Healthscope Limited. Due to the sequence of events associated with the acquisition process, including the premature disclosure of non-public information regarding Tenet's preliminary interest in Healthscope, Tenet has been unable to complete the work necessary to thoroughly convey to shareholders the potential value, including the inherent risks and opportunities, of this transaction.
Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Friday, December 7, 2012.
› Verified 5 days ago
Dr. Wendy Elizabeth Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Cochituate Rd, Framingham, MA 01701 Phone: 508-628-9660 Fax: 508-628-9668 | |
Dr. Sira Korpaisarn, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 | |
Dagem Getahun, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1555 | |
Dr. Pedro Arthur Macedo De Freitas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Yung-chen Wu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1572 | |
Richard Stephen Blumenfeld, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-879-7904 Fax: 508-872-8594 | |
Rejane Guerrier, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 959 Concord St Ste 200, Framingham, MA 01701 Phone: 508-532-0223 Fax: 508-875-0049 |